Skip to main content
Caplight Logo









CaaMTech

CaaMTech

Private
Issaquah, WashingtonHealthcare & Life Scienceshttps://caam.tech/

Last Round

Series A

Sep 8, 2021

Total Funding Raised

$23.35M

Company Overview

CaaMTech is a pharmaceutical drug discovery company that engineers and optimizes novel psychedelic-inspired small-molecule therapeutics to treat mental health conditions.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Mental Health

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

drug discoverypsychedelic therapeuticssmall-molecule drugsserotonergic therapeuticspsychedelic medicineintellectual property licensinglead optimizationneuroplastogensmental health treatmentcomputational drug discoveryIP licensingbiotech researchpsychedelic researchdrug developmentAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CaaMTech Comparables

Compare CaaMTech with similar companies based on industry and business-model similarity.

CaaMTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Psilera
87%
Gilgamesh Pharmaceuticals
86%
Lophora
83%

CaaMTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 8, 2021

Key People

Founding team and executive leadership

Andrew Chadeayne

Founder And Chief Executive Officer

Founding Team

CaaMTech Investors

Notable investors and investment history

CaaMTech investors
InvestorRounds
Noetic FundSeries A
Mont Alto CapitalSeries A
Kortschak InvestmentsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 159% MoM, reaching 4.1K.

  • Sep 8, 2021

    $22M round led by Noetic Fund.

CaaMTech Filings

Explore SEC and related filing metadata, where available.

CaaMTech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CaaMTech's valuation, stock price, and market status.

Is CaaMTech a public or private company?

CaaMTech is a private company.

What is the current stock price of CaaMTech?

CaaMTech is a private company with no public stock price. No recent secondary market data is available.

How much is CaaMTech worth (valuation)?

Valuation information for CaaMTech is not publicly available.

Can I buy CaaMTech stock?

CaaMTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CaaMTech's last funding round?

CaaMTech's most recent funding round was Series A on September 8, 2021.

Who are the main investors in CaaMTech?

Key investors in CaaMTech include Noetic Fund.

Will CaaMTech IPO soon?

No public IPO plans have been announced for CaaMTech.

How can I track CaaMTech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CaaMTech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIssaquah, Washington
Employee Range4
Year Founded2019
Last FundingSep 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?